文献速递肺外科

倾向性匹配比较VATS左上肺三段切除与肺叶切除

Propensity-matched Comparison of VATS Left Upper Trisegmentectomy and Lobectomy.
PubMed 文献 · Ann Thorac Surg · 2021-08-21

回顾性分析2013至2017年上海肺科医院1543例I期NSCLC患者,倾向性匹配后273对接受VATS左上肺三段切除(LTS)或左上肺叶切除(LUL)。

要点

  • I期NSCLC行VATS左上肺三段切除与肺叶切除的肿瘤学结局相当。

核心结论

  • 对于I期NSCLC,只要确认切缘阴性,VATS左上肺三段切除与左上肺叶切除的肿瘤学结局相当,不受肿瘤病理类型和影像学表现影响。

研究设计与样本

  • 回顾性分析2013至2017年上海肺科医院1543例连续接受VATS左上肺三段切除或左上肺叶切除的NSCLC患者,倾向性评分匹配后纳入273对。

主要发现

  • 切缘-肿瘤比两组无统计学差异(2.5±1.6 vs 2.3±1.1,P=0.11)。

临床怎么用

  • 对于I期NSCLC,在确认切缘阴性的前提下,VATS左上肺三段切除可作为左上肺叶切除的替代选择。

局限性

  • 本研究为单中心回顾性分析,结论需前瞻性研究进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study aimed to investigate the oncologic outcomes of video-assisted thoracoscopic (VATS) left upper trisegmentectomy (LTS) vs left upper lobectomy (LUL) for patients presenting with stage I non-small cell lung cancer (NSCLC). METHODS: A retrospective analysis identified 1543 consecutive patients presenting to Shanghai Pulmonary Hospital (Shanghai, China) with NSCLC for VATS LTS or LUL from 2013 to 2017. After propensity-score matching for patient demographics and tumor characteristics, 273 pairs were identified. Disease-free survival (DFS) and overall survival (OS) were estimated by the Kaplan-Meier method and compared using the log-rank test. RESULTS: The median follow-up time was 51.5 months. There were no significant differences in operative duration (2.11 ± 0.64 hours vs 2.49 ± 5.96 hours; P = .30), total blood loss (106.19 ± 170.83 mL vs 97.07 ± 149.34 mL; P = .51), and operative complications (10% vs 8%; P = .37) between the LUL and LTS groups. Patients undergoing LUL had longer postoperative hospital stays (5.55 ± 3.00 days vs 4.87 ± 2.33 days; P = .003), greater tumor margin distance (3.3 ± 1.2 cm vs 3.1 ± 0.9 cm; P < .001), and greater number of lymph nodes harvested (8.0 ± 3.2 vs 6.8 ± 3.3; P < .001) than patients undergoing LTS, but the margin-to-tumor ratio was not statistically different (2.5 ± 1.6 vs 2.3 ± 1.1; P = 0.11). Median DFS (49.5 months vs 54.3 months; P = .77) and OS (49.5 months vs 55.0 months; P = .88) were not significantly different between patients undergoing LTS and those undergoing LUL, and similar outcomes were noted across subgroups of patients stratified by tumor stage, pathologic type, and radiographic manifestations. CONCLUSIONS: VATS LTS and LUL had comparable oncologic outcomes for stage I NSCLC, regardless of tumor pathologic types and radiologic findings, as long as negative margins were confirmed.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Zhou B, Xu X, Dai J, et al. Propensity-matched Comparison of VATS Left Upper Trisegmentectomy and Lobectomy. Ann Thorac Surg. 2021. PMID: 34428431. doi:10.1016/j.athoracsur.2021.07.057

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。